This pilot study will assess the safety and effectiveness of UV light treatment in hospitalized patients with COVID-19.
This is a single center, open label, pilot study. 5 adult patients, aged over 18, who are confirmed positive with SARS-CoV-2 and are newly intubed, will receive UV light treatment to reduce SARS-CoV-2 viral load.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
5
UV light therapy administered while patient is mechanically ventilated
Cedars-Sinai Medical Center
Los Angeles, California, United States
Negative Change in Viral Load
Change of viral load in upper airway in patients admitted to hospital for COVID-19
Time frame: 5 days
Change in Bacterial Load
Change of bacterial load in upper airway
Time frame: 5 days
Ventilated Associated Pneumonia
Percentage of patients developing ventilated pneumonia (VAP) within 30 days of treatment
Time frame: 1 month
Days to Extubation
Number of days patient is intubated with endotracheal tube or tracheostomy
Time frame: 1 month
Days to Discharge
Number of days patient is discharged from the hospital
Time frame: 1 month
Change in C-reactive Protein
Change in C-reactive protein from baseline to the end of the treatment
Time frame: 5 days
Change in the World Health Organization (WHO) Coronavirus Disease (COVID)-19 10-point Ordinal Severity Scale by 30 Days
The World Health Organization (WHO) COVID-19 10-point ordinal severity scale: 0 uninfected, No viral RNA detected 1. Asymptomatic; viral RNA detected 2. Ambulatory Mild disease: Symptomatic; independent 3. Ambulatory Mild disease: Symptomatic; assistance needed 4. Hospitalized: Moderate disease; no oxygen therapy 5. Hospitalized: Moderate disease; oxygen by mask or nasal prongs 6. Hospitalized: sever disease, Oxygen by non-invasive ventilation or high flow 7. Hospitalized: severe disease, intubation and mechanical ventilation, pO2/FiO2\>=150 or SpO2/FiO2\>=200 8. Hospitalized: severe disease, Mechanical ventilation pO2/FiO2\<150(SpO2/FiO2 \<200) or vasopressors 9. Hospitalized: severe disease, Mechanical ventilation pO2/FiO2\<150 and vasopressors, dialysis or extracorporeal membrane oxygenation 10. Death
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 1 month
Catheter Tip Assessment on the Last Day of Treatment
Assessment of total bacterial load on the UV catheter tip on the last day of treatment
Time frame: 5 days